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Abstract It is known for smooth muscle myosin that while acto- 
HMM ATPase activity is regulated by phosphorylation, acto-S-1 
ATPase activity is not regulated. To clarify the heavy chain 
structure required for the regulation, smooth muscle myosin con- 
taining 7 different lengths of the S-2 portion were expressed in 
Sf9 insect ceils using Baculovirus expression system. Myosin 
containing longer than 991 residues of heavy chain formed a 
stable two-headed structure while myosin with shorter than 944 
residues of heavy chain formed a single-headed structure, indicat- 
ing that the residues Gln94S-Asp 99~ are critical for the fomation 
of the two-headed structure. The actin activated ATPase activity 
of myosin mutants having a two-headed structure was activated 
by phosphorylation while that of myosin mutants that failed to 
form the two-headed structure was completely independent of 
phosphorylation. These results suggest hat the two-headed struc- 
ture is critical for the phosphorylation-dependent regulation. 
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the elimination of the C-terminal residues of the light chain 
abolishes phosphorylation-dependent activation of actomyosin 
motor [13,14], suggesting that the phosphorylation i duced 
conformational change is transmitted to heavy chain via the 
C-terminal domain of the light chain. While the light-chain 
binding site is within the S-1 domain of myosin the phosphoryl- 
ation-dependent regulation requires the S-2 domain since S-1 
containing the intact light chains is not regulated by phospho- 
rylation whereas HMM containing the S-2 domain is regulated 
[15]. The importance of the S-2 region for regulation is sup- 
ported by a series of findings [15-20] that the conformation at 
the S-1-S-2 junction of smooth muscle myosin is altered by light 
chain phosphorylation. To further elucidate the function of the 
S-2 domain on the regulatory mechanism, we produced various 
myosin mutants which contain various lengths of the S-2 por- 
tion using a Baculovirus expression system. 
2. Materials and methods 
1. Introduction 
It is known that the motor activity of vertebrate smooth 
muscle and non-muscle acto myosin is activated by phosphoryl- 
ation of the 20,000 Da light chain subunit of myosin catalyzed 
by a Ca2+/calmodulin-dependent protein kinase, myosin light 
chain kinase (MLC kinase) [1-3]. The activation of actomyosin 
requires the phosphorylation f rather specific sites, i.e. Ser -19 
and Thr-~8 [4-7] and the phosphorylation at Serl/Ser 2 and Thr -9 
catalyzed by protein kinase C [8,9] failed to activate actomyosin 
motor activity [8-10]. The question is how the phosphorylation 
at Ser~9/Thr TMof the 20,000 Da light chain can activate acto- 
myosin motor activity. It is unlikely that the phosphate moiety 
interacts directly with the effector sites, i.e. the ATP binding site 
and/or actin binding site, because the light chain is localized at 
the head-rod junction [11-12] which is quite distal to the effec- 
tor sites located towards the top of the myosin head [11]. It is 
plausible that the phosphorylation changes the conformation 
of the 20,000 Da light chain which is transmitted to the myosin 
heavy chain thus changing the motor activity. This view is 
supported by recent findings that the C-terminal domain of the 
20,000 Da light chain is important for regulation [12-14] and 
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dodecylsulfate polyacrylamide gelelectrophoresis; PMSF, phenylmeth- 
ylsulfonyl fluoride. 
2.1. Materials 
Smooth muscle myosin was prepared from frozen turkey gizzards as 
described previously [21]. Actin was prepared from rabbit skeletal mus- 
cle acetone powder according to Spudich and Watt [22]. Myosin light 
chain kinase was prepared from frozen turkey gizzards [23]. Calmod- 
ulin was prepared from bull testes [24]. Myosin light chains were pre- 
pared from smooth muscle myosin according to Hathaway and Haebele 
[25] with modification [26]. 
2.2. Construction fmyosin heavy chain expression vector and 
expression of the recombinant myosin heavy chain 
The cDNA containing entire open reading frame of myosin heavy 
chain was obtained from chicken gizzard 2zap cDNA library using 
oligonucleotide probes designed according to the published sequence 
[27]. The screening was carried out as described previously [7] and the 
sequence was confirmed by dideoxynucleotide termination method [28] 
using Sequenase 2.0 (US Biochemical). 
pBluescript SKII(-) containing myosin heavy chain cDNA (-44- 
6,016) was excised automatically from 2 phage on M13 helper phage 
infection. Using a transformer Site Directed Mutagenesis Kit (Clontech 
Inc.), endogenous nique SpeI site was deleted without changing amino 
acid residues and an additional Spel site was created at the 19th posi- 
tion (Fig. 1). Using the same site directed mutagenesis strategy, a stop 
codon was introduced at 2,551, 2,617, 2,833, 2,974, 3,331, or 3,439, thus 
producing the truncated heavy chains of Met~-Leu 85°, Met l -Glu 872, 
MeP-Ser 9~4, Mete-Gin 957, Mete-Asp 99~, Metl-Ser m°, or Met~-Glu a~5~, 
respectively. The myosin heavy chain cDNA in SKII(-) was digested 
with SpeI and subcloned into pBlueBacM Baculovirus transfer vector 
using unique NheI site in the multicloning site which is localized own- 
stream of the polyhydrin promotor (Fig. 1). The recombinant smooth 
muscle myosin heavy chains were expressed in the insect cells by the 
protocol described [29]. 
2.3. Other biochemical procedures 
SDS PAGE was carried out on 7.5% polyacrylamide slab gels by 
using the discontinuous buffer system of Laemmli [30]. Molecular mass 
markers used were smooth muscle myosin heavy chain (200 kDa), 
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fl-galactosidase (116 kDa), phosphorylase a (97.4 kDa) and bovine 
serum albumine (66 kDa). Western blotting was performed as described 
previously [20] with modification [31]. ATPase activity of the recombi- 
nant myosin fragments was measured as described previously [15]. The 
protein concentration of myosin was estimated from densitometric 
analysis of the gel (USB Sciscan 5000, US Biochemical, Cleveland, OH) 
using natural myosin as a standard. 
2.4. Preparation of the recombinant myosin heavy chain mutants 
Sf-9 cells infected with the recombinant virus were harvested after 
72 h infection and lysed with 5 vol. of the buffer containing 400 mM 
KCI, 50 mM Tris-HCl (pH 7.5), 10 mM MgC12, 0.2 mM EGTA, 10 mM 
ATP, 5 mM DTT, 2 mM PMSF, 2 mM N~-p-Tosyl-L-arginine m th- 
ylester, 0.2 mM Nc~-p-Tosyl-L-phenylalanine chloromethyl ketone, 0.2 
mM Not-p-Tosyl-L-lysine chloromethyl ketone, 0,01 mg/ml ofleupeptin, 
1 mg/ml of trypsin inhibitor, 0.5% Triton X-100, 1% NP-40, 1 M 
monosodium glutamate, 100 ¢tg/ml of 20,000 Da light chain and 100 
mg/ml of 17,000 Da light chain with sonication. The cell lysate was 
subjected to 30-35% ammonium sulfate fractionation. The resulting 
precipitates were collected and dissolved in 3 ml of 400 mM KC1, 50 
mM Tris-HCl (pH 7.5), 5 mM DTT, 0.2 mM PMSF and 0.01 mg/ml 
leupeptin. The solution was clarified by centrifugation and the resulting 
clear supernatant was applied to a column (2.5 × 20 cm) of G-25 which 
had been equilibrated with 400 mM KC1, 50 mM Tris-HCl (pH 7•5), 
5 mM DTT and 0.2 mM PMSF. Proteins were eluted with the same 
buffer and the first peak was collected. F-actin (final concentration f 
1 mg/ml) was added to this fraction and the recombinant myosin was 
coprecipitated with centrifugation (100,000 x g for 30 rain). The pellet 
was washed with the same buffer then washed with 15 mM KC1, 30 mM 
Tris-HC1 (pH 7.5), 1 mM DTT, 0.2 mM PMSF and 10 mM MgCI~. The 
pellet was dissolved with the buffer containing 0.1 mM ATP then 
centrifuged at 100,000 x g for 30 min. The supernatant containing the 
recombinant myosin was subjected to the assay, 
3. Results and discussion 
Smooth muscle myosin heavy chains with various tail lengths 
were expressed in the insect cell line Sf9. Fig. 2A shows SDS 
PAGE of Sf9 cell total homogenate expressing various trun- 
cated myosin heavy chain mutants. Apparent molecular mass 
of the seven truncated mutants were 134 kDa, 128 kDa, 114 
kDa, l l0kDa, 108 kDa, 100 kDa and 97 kDa which were 
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Fig. 1. Construction of smooth muscle myosin heavy chain Baculovirus expression vector (pBlue 6D3). cDNA encoding entire open reading frame 
of gizzard myosin heavy chain was cut with EeoRl and SpeI and the fragment was subcloned into pBluscript SKII vector. SpeI site was introduced 
at -19 position and a stop codon was introduced at various ites using site directed mutagenesis strategy as described [31]. The myosin heavy chain 
cDNA was cut with Spel digestion and the fragment was subcloned into pBlueBac M Baculovirus transfer vector. 
248 M. Matsu-ura, M. Ikebe/FEBS Letters 363 (1995) 246-250 
(A) (B) 
1 2 3 4 5 6 7 8 1 
200 k Da 
i 
116kDa 
97kDa 
66kDa 
2 3 4 5 6 7 8 
200kDa 
116kDa 
97kDa 
Fig. 2. SDS PAGE and immunoblots of the expressed truncated smooth muscle myosin mutants. (A) Coomassie brilliant blue stained gel. Lane I, 
97 kDa; lane 2, 100 kDa; lane 3, 108 kDa; lane 4, 110 kDa; lane 5, 114 kDa; lane 6, 128 kDa; lane 7, 134 kDa heavy chain mutants, respectively. 
lane 8, molecular weight standard. (B) Immunoblotting of the gel. Anti myosin heavy chain monoclonal ntibody (ram-3) which recognizes the 
68 kDa N-terminal domain was used as a probe. Lanes are as described above. 
consistent with the expected polypeptide length, i.e. 1,153, 
1,110, 991,957,944, 872, and 850, respectively. The authenticity 
of these peptide bands was confirmed by western blotting anal- 
ysis (Fig. 2B) using a monoclonal antibody, mm-3, which recog- 
nizes the 68 kDa N-terminal fragment of smooth muscle S-1. 
To determine whether the truncated heavy chain mutants 
form a two-headed structure ov one-headed structure, the ex- 
pressed myosin mutants were subjected to gel filtration analy- 
sis. The elution position of myosin was monitored by measuring 
K ÷ EDTA ATPase activity of myosin (Fig. 3). The myosin 
containing the 134 kDa heavy chain eluted from the gel filtra- 
tion column at the same position as naturally isolated gizzard 
HMM suggesting that the 134 kDa heavy chain forms a two- 
headed structure (Fig. 3). On the other hand, the 100 kDa heavy 
chain eluted at the elution volume similar to the naturally iso- 
lated gizzard S-I, thus forming a single-headed structure (Fig. 
3). The l l0  kDa heavy chain showed two active peaks. The 
molecular weight of these two active peaks were estimated 
according to the elution volumes. It was revealed that the elu- 
tion volume of the first peak corresponds to the expected elu- 
tion volume of a two-headed structure while that of the second 
peak corresponds to the elution volume of a single-headed 
structure. The proportion of the two-headed vs. the single- 
headed form of each truncated myosin heavy chain was esti- 
mated according to K ÷ EDTA ATPase activity of each peak. 
As shown in Table l, myosin heavy chain formed the two- 
Table 1 
Relative amount of the single-headed and double-headed forms of 
myosin mutants 
Molecular weight 
of heavy chain 
Relative amount of myosin (%)" 
Double-headed form Single-headed form 
98 kDa 0.0 100 
100 kDa 0.0 100 
108 kDa ND ND 
110 kDa 63 37 
114 kDa 81 19 
128 kDa 98 1.7 
134 kDa 100 0.0 
"The amount of myosin was estimated by measuring the EDTA ATPase 
activity of the gel filtration fractions as described in Fig. 3. 
headed structure when its molecular weight was above 114 kDa 
while all myosin fragments below 100 kDa were the single- 
headed type. On the other hand, both two-headed and single- 
headed structures were present with the heavy chain molecular 
mass of 110 kDa (Fig. 3, Table 1). When the heavy chain was 
further truncated by 2 kDa, no obvious two-headed myosin 
peak was observed (Fig. 3), however, the activity peak was 
asymmetrical with the maximum at the position of the single- 
headed myosin. The result suggests that the single-headed form 
is dominant and that the two-headed form of the 108 kDa 
heavy chain is unstable and in relatively fast equilibrium with 
the single-headed form. To examine whether or not the double- 
headed structure is stable for the 110 kDa construct, the dou- 
ble-headed fractions were rechromatographed (Fig. 3). The activ- 
ity was eluted at the position of the single-headed myosin 
suggesting that the association of the two heavy chains is not 
very stable which was different from the longer heavy chain 
construct which showed a stable two-headed structure (not 
shown). These results indicate that the residues Gln945-Ser 991 
are critical for the formation of double-headed structure of 
myosin. 
The expressed myosin heavy chain in cell homogenate was 
hybridized with both 20,000 Da and 17,000 Da light chains and 
coprecipitated with F-actin. The precipitates were dissolved 
with ATP containing buffer and the recombinant myosin was 
recovered from the supernatant after centrifugation. As shown 
in Table 2, the 134 kDa mutant showed significant phosphoryl- 
ation-dependent actin activated ATPase activity (74 nmol/min/ 
nag). Similar phosphorylation-dependent activity was obtained 
for naturally isolated HMM (data not shown, see also [15]). 
Myosin heavy chain (134 kDa) was also coexpressed with the 
20,000 Da and 17,000 Da light chains in the insect cell line Sf9. 
The purified myosin fragment showed similar phosphorylation 
dependent actin activated ATPase activity (data not shown). 
While the phosphorylation-dependent activity was observed 
with the myosin fragments with greater than 114 kDa of heavy 
chain, the myosin fragments with less than 108 kDa of heavy 
chain showed virtually no phosphorylation dependence (Table 
2). As shown in Fig. 2, the 110 kDa heavy chain formed both 
two-headed and one-headed myosin. The myosin fragments in 
each active peak of Sephacryl S-300 fractions were immediately 
subjected to the actin-coprecipitation step for purification (see 
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Fig. 3. Elution profile of Sephacryl S-300 HR gel filtration of various mooth muscle myosin truncation mutants. Coinfected Sf9 cells were harvested 
and lysed after 72 h of infection. The lysate in the presence of two classes of light chains was applied to Sephacryl S-300 HR column (2.5 cmx 100 
cm) equilibrated with 0.6 M KC1, 50 mM Tris-HC1 (pH 7.5), 1 mM ATP, 1 mM MgCI2, 1 mM DTT, and 1 M monosodium glutamate. The fractions 
(7 ml/tube) were collected at a flow rate of 40 ml/h. EDTA-ATPase activity of each fraction was measured at 25°C in the solution containing 
0.6 M KC1, 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.5 mM [y-s2p]ATP (500 cpm/nmol). (A) 134 kDa mutant; (B) 110 kDa mutant; (C) 108 kDa 
mutant; (D) 100 kDa mutant; (E) rechromatography of the 1st peak of B. 
section 2), The ATPase activity of the engineered myosins was 
then determined. 
The single-headed fraction did not show any phosphoryla-  
tion dependent ATPase activity while the double-headed frac- 
t ion showed phosphorylat ion-dependent activity although the 
value was significantly lower than the longer heavy chain mu- 
250 
Table 2 
Phosphorylation dependence of the actin activated ATPase activity of 
the truncated myosin mutants 
Actin activated Mg-ATPase (nmol PJmin, mg)" 
Molecular Dephos- Phosphorylated Phosphorylation- 
weight of phorylated dependent 
myosin heavy chain activity 
98 kDa 90 90 0 
100 kDa 92 105 13 
108 kDa 99 99 0 
110 kDa 95 97 2 
single-headed 
110 kDa 81 105 23 
double-headed 
114 kDa 63 141 78 
128 kDa 51 101 50 
134 kDa 44 118 74 
"Actin activated Mg2+-ATPase activity was measured at 25°C in 50 mM 
KC1, 30 mM Tris-HC! (pH 7.5), 2 mM MgC12, with or without 3 mg/ml 
F-actin. 0.1 mM Ca2+C12, 10/tg/ml MLCK, 5/.tg/ml calmodulin or 
1 mM EGTA were added for phosphorylated or dephosphorylated 
myosin, respectively. 
tants (Table 2). Considering that the longer heavy chain mu- 
tants form double-headed myosin while the shorter heavy chain 
mutants form single-headed myosin, one can conclude that the 
phosphorylation-dependent r gulation requires the double- 
headed structure of myosin molecule. The lower extent of phos- 
phorylation dependence of the double-headed 110 kDa heavy 
chain mutant is likely to be due to the low stability of the 
double-headed structure (Fig. 3). Quite recently while this study 
was underway, it was reported that [32] smooth muscle HMM 
with a longer tail has higher phosphorylation dependence than 
HMM with a shorter tail. Our data is consistent with this 
notion and provides further evidence for the hypothesis that the 
double-headed structure is critical for the phosphorylation- 
dependent regulation. 
It is known that S- 1 is active without phosphorylation, there- 
fore, it is plausible that each myosin head itself is active without 
phosphorylation a d the possible intra-molecular head interac- 
tion is critical for the regulation of smooth muscle myosin 
motor activity. When myosin is dephosphorylated the resulting 
head interaction may inhibit the motor activity. The results of 
the present study clearly support his hypothesis. It is known 
that the 20,000 Da light chain resides at the S-1-S-2 junction 
[11] and the phosphorylation of this light chain induces a con- 
formational change at the head rod junction [17-20]. There- 
fore, it may be postulated that the role of light chain phospho- 
rylation is to change the conformation at S-1-S-2 junction so 
as to disrupt the interaction between the two heads which is 
critical for the inhibition of myosin motor activity. The under- 
standing of the detailed mechanism of the phosphorylation 
mediated regulation requires further study. 
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